Resurgence in COVID Infections Across the Americas 14/07/2021 Raisa Santos Though new COVID-19 cases are down nearly 20% from last week in the Americas, many countries are experiencing a resurgence in infections, officials from the Pan American Health Organization (PAHO) announced at a press briefing on Wednesday. Over 962,280 new cases were reported in the region in the past week, according to data from the […] Continue reading -> Call for White House to “Clear the Air’ on Cuban Economic Sanctions Policy – With Respect to COVID Vaccines 02/07/2021 Raisa Santos The Biden administration has been asked to clarify that sanctions against Cuba would not extend to collaborations in the development, manufacturing, distribution and sale of COVID-19 vaccines that the island nation is in the process of developing. A memorandum, sent by Knowledge Ecology International (KEI) on 28 June to the White House, asks the US […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> U.S. Will Pay WHO Over $200 Million By End of February 17/02/2021 Editorial team The United States will pay over $200 million it owes to the WHO by the end of February, marking a positive step to restabilize the global health body’s fragile finances at a time when they are most needed. “This is a key step forward in fulfilling our financial obligations as a WHO member and it […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Posts navigation Older postsNewer posts
Call for White House to “Clear the Air’ on Cuban Economic Sanctions Policy – With Respect to COVID Vaccines 02/07/2021 Raisa Santos The Biden administration has been asked to clarify that sanctions against Cuba would not extend to collaborations in the development, manufacturing, distribution and sale of COVID-19 vaccines that the island nation is in the process of developing. A memorandum, sent by Knowledge Ecology International (KEI) on 28 June to the White House, asks the US […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> U.S. Will Pay WHO Over $200 Million By End of February 17/02/2021 Editorial team The United States will pay over $200 million it owes to the WHO by the end of February, marking a positive step to restabilize the global health body’s fragile finances at a time when they are most needed. “This is a key step forward in fulfilling our financial obligations as a WHO member and it […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Posts navigation Older postsNewer posts
Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> U.S. Will Pay WHO Over $200 Million By End of February 17/02/2021 Editorial team The United States will pay over $200 million it owes to the WHO by the end of February, marking a positive step to restabilize the global health body’s fragile finances at a time when they are most needed. “This is a key step forward in fulfilling our financial obligations as a WHO member and it […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Posts navigation Older postsNewer posts
Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> U.S. Will Pay WHO Over $200 Million By End of February 17/02/2021 Editorial team The United States will pay over $200 million it owes to the WHO by the end of February, marking a positive step to restabilize the global health body’s fragile finances at a time when they are most needed. “This is a key step forward in fulfilling our financial obligations as a WHO member and it […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Posts navigation Older postsNewer posts
United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> U.S. Will Pay WHO Over $200 Million By End of February 17/02/2021 Editorial team The United States will pay over $200 million it owes to the WHO by the end of February, marking a positive step to restabilize the global health body’s fragile finances at a time when they are most needed. “This is a key step forward in fulfilling our financial obligations as a WHO member and it […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Posts navigation Older postsNewer posts
Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> U.S. Will Pay WHO Over $200 Million By End of February 17/02/2021 Editorial team The United States will pay over $200 million it owes to the WHO by the end of February, marking a positive step to restabilize the global health body’s fragile finances at a time when they are most needed. “This is a key step forward in fulfilling our financial obligations as a WHO member and it […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Posts navigation Older postsNewer posts
Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> U.S. Will Pay WHO Over $200 Million By End of February 17/02/2021 Editorial team The United States will pay over $200 million it owes to the WHO by the end of February, marking a positive step to restabilize the global health body’s fragile finances at a time when they are most needed. “This is a key step forward in fulfilling our financial obligations as a WHO member and it […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Posts navigation Older postsNewer posts
Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> U.S. Will Pay WHO Over $200 Million By End of February 17/02/2021 Editorial team The United States will pay over $200 million it owes to the WHO by the end of February, marking a positive step to restabilize the global health body’s fragile finances at a time when they are most needed. “This is a key step forward in fulfilling our financial obligations as a WHO member and it […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Posts navigation Older postsNewer posts
U.S. Will Pay WHO Over $200 Million By End of February 17/02/2021 Editorial team The United States will pay over $200 million it owes to the WHO by the end of February, marking a positive step to restabilize the global health body’s fragile finances at a time when they are most needed. “This is a key step forward in fulfilling our financial obligations as a WHO member and it […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Posts navigation Older postsNewer posts
Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Posts navigation Older postsNewer posts